Canopy Growth Corporation (CGC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Canopy Growth Corporation (CGC:NASDAQ), powered by AI.

Current Price
$1.00
P/E Ratio
-0.2
Market Cap
108M
Sector
Healthcare
What is the Canopy Growth Corporation stock price forecast?

Canopy Growth Corporation is currently trading at $1.00. View real-time AI analysis on Alpha Lenz.

What is Canopy Growth Corporation insider trading activity?

View the latest insider trading data for Canopy Growth Corporation on Alpha Lenz.

What is Canopy Growth Corporation's P/E ratio?

Canopy Growth Corporation's P/E ratio is -0.2.

Canopy Growth Corporation

NASDAQ · CGC
$1.00-0.01(-0.99%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Canopy Growth Corporation's future dividend policy...
Alpha Chat Insight

Canopy Growth Corporation trades at a P/E of -0.2 (undervalued) with modest ROE of -121.1%.

Ask for details

Company Overview

Canopy Growth Corporation is a leading player in the cannabis and hemp industry, headquartered in Canada. The company's primary function is the production and distribution of both recreational and medicinal cannabis products. Canopy Growth Corporation is known for its extensive portfolio that includes dried flower, oils, softgel capsules, and edibles, catering to diverse consumer preferences and medical needs. With a focus on innovation, Canopy Growth invests heavily in research and development to enhance its product offerings and maintain a competitive edge in the rapidly evolving cannabis sector. The corporation also leverages strategic partnerships and acquisitions to expand its market presence globally, reflecting its significance as a pioneer in the legalization and commercialization of cannabis. As one of the largest cannabis companies by market capitalization, Canopy Growth plays a crucial role in shaping industry standards and regulations, further influencing the legalization discourse across various countries as the market matures.

CEOMr. Luc Mongeau
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees960

Company Statistics

FY 2025

Profile

$107.55MMarket Cap
$269.00MRevenue
0.00Shares Out
960Employees

Margins

29.56%Gross
-6.18%EBITDA
-24.68%Operating
-221.94%Pre-Tax
-222.35%Net

Valuation

-0.18P/E
0.22P/B
0.40EV/Sales
-20.58EV/EBITDA
-0.61P/FCF

Growth (CAGR)

-17.31%Rev 3Yr
-7.57%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-53.93%ROA
-121.13%ROE
-47.11%ROIC

Financial Health

$113.81MCash & Cash Equivalents
$316.68MNet Debt
88.36%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Canopy Growth Corporation (ticker: CGC) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 960 employees. Market cap is $108M.

The current price is $1 with a P/E ratio of -0.18x and P/B of 0.22x.

ROE is -121.13% and operating margin is -24.68%. Annual revenue is $269M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Canopy Growth Corporation (CGC) Stock Forecast 2026 $1.00 — Price, Financials & Analyst Targets | Alpha Lenz